세계의 임상 검사 서비스 시장 : 어세이 유형별, 장소별, 제품별, 국가별 예측과 전략 및 동향 - 경영진 및 컨설턴트 가이드 포함 - 제8판(2025-2029년)
Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides - 8th Edition. 2025 to 2029
상품코드:1764337
리서치사:Howe Sound Research
발행일:2025년 06월
페이지 정보:영문 373 Pages
라이선스 & 가격 (부가세 별도)
한글목차
임상 실험실은 COVID의 도전에 직면했지만, 팬데믹의 종식은 진단에 대한 새로운 접근 방식을 만들어 냈습니다. 현장 진료와 자가 검사는 임상 검사 서비스에 대한 장기적인 수요를 위협하고 있지만, 분자진단은 급격한 성장을 주도하고 있습니다. 이 종합적인 보고서를 통해 기회와 위협을 이해할 수 있습니다.
임상 검사는 생명공학, 특히 유전체학의 폭발적인 발전의 직접적인 수혜를 받을 수 있는 위치에 있습니다. 여러 가지 역동적인 동향이 시장의 성장과 기업의 가치를 높이고 있습니다.
이 보고서는 분석가와 기획자가 활용할 수 있는 데이터를 제공합니다. 본 보고서에는 15개국 및 4개 지역에 대한 상세한 분석이 포함되어 있습니다. 보고서 구매자는 전 세계 모든 국가별 세부 분석 자료를 이용할 수 있습니다.
The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.
The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.
The report provides data that analysts and planners can use. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Table of Contents
1. Market Guides
1.1. Strategic Situation Analysis
1.2. Guide for Executives, Marketing, Sales and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors
2. Introduction and Market Definition
2.1. The New Demand for Clinical Testing
2.2. Defining the Opportunity
2.2.1. Revenue Market Size
2.3. Methodology
2.3.1. Methodology
2.3.2. Sources
2.3.3. Authors
2.4. Perspective: Healthcare and the IVD Industry
2.4.1. Global Healthcare Spending
2.4.2. Spending on Diagnostics
2.4.3. Important Role of Insurance for Diagnostics
3. Overview of a Dynamic Market
3.1. Players in a Dynamic Market
3.1.1. Academic Research Lab
3.1.2. Diagnostic Test Developer
3.1.3. Instrumentation Supplier
3.1.4. Chemical/Reagent Supplier
3.1.5. Pathology Supplier
3.1.6. Independent Clinical Laboratory
3.1.7. Public National/regional Laboratory
3.1.8. Hospital Laboratory
3.1.9. Physicians Office Lab (POLS)
3.1.10. Audit Body
3.1.11. Certification Body
3.2. Segmentation - Different Approaches
3.2.1. Traditional Market Segmentation
3.2.2. Laboratory Focus and Segmentation
3.3. Structure of Clinical Testing Industry
3.3.1. The Hospital Lab - Share of the Pie
3.3.2. Key Role for Economies of Scale
3.3.3. Physician Office Lab's are Still Here
3.3.4. Physician's and POCT - Reviving Patient Service in China
3.4. National and Regional Diversity
4. Trends Driving a Changing Market
4.1. Growth Is Pushed from Many Sides
4.1.1. Demographic Impacts on Consumption
4.1.2. COVID Related Impacts
4.1.3. Point of Care Testing Makes a Difference
4.1.4. Alternative Medicine Effect
4.1.5. Esoterics
4.1.6. A New Laboratory Discipline
4.2. Factors at Work to Shrink the Market
4.2.1. Where are Costs Going?
4.2.2. Population Effects
4.2.3. Management Practices
4.2.4. Wellness
4.2.5. Cannabilization
4.2.6. Point of Care
4.3. Automation and Laboratory Trends
4.3.1. Traditional Automation and Centralization
4.3.2. The New Automation, Decentralization and Point Of Care
4.3.3. Instruments Key to Market Share
4.3.4. Bioinformatics Plays a Role
4.3.5. PCR Takes Command
4.3.6. Next Generation Sequencing Fuels a Revolution
4.3.7. NGS Impact on Pricing
4.3.8. Whole Genome Sequencing, A Brave New World
4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
